Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis
NACompletedINTERVENTIONAL
Enrollment
25
Participants
Timeline
Start Date
December 31, 1999
Study Completion Date
February 28, 2005
Conditions
Kidney Failure, Chronic
Interventions
DRUG
growth hormone
Trial Locations (1)
37232-2516
Vanderbilt University Medical Center, Nashville
All Listed Sponsors
collaborator
Vanderbilt University
OTHER
lead
FDA Office of Orphan Products Development
FED
NCT00004429 - Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis | Biotech Hunter | Biotech Hunter